ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,685, issued on Nov. 4, was assigned to VectivBio AG (Basel, Switzerland).
"Manufacture, formulation and dosing of apraglutide" was invented by Federico Bolognani (Biel-Benken, Switzerland) and Gleb Feldman (Oxford, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to methods of making, formulating and administering GLP-2 analogs."
The patent was filed on Aug. 31, 2021, under Application No. 17/462,908.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d...